Delayed hypersensitivity reaction to the preservative myristyl picolinium chloride.
Goulden
V
V
Dermatology Department, General Infirmary at Leeds, UK.
Goodfield
M J
MJ
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002648:Child; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077555:Methylprednisolone Acetate; D009227:Myristic Acids / Q000009:adverse effects*; D010847:Picolines / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D009227:Myristic Acids; D010847:Picolines; C054770:1-myristylpicolinium; D000077555:Methylprednisolone Acetate; D008775:Methylprednisolone